Previous Close | 13.62 |
Open | 13.73 |
Bid | 14.22 x 400 |
Ask | 14.32 x 300 |
Day's Range | 13.73 - 14.29 |
52 Week Range | 9.57 - 21.60 |
Volume | |
Avg. Volume | 448,913 |
Market Cap | 534.54M |
Beta (5Y Monthly) | 1.03 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.12 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.47 |
LEWISVILLE, Texas, March 18, 2024--Former NuVasive executive joins Orthofix as Chief People and Business Operations Officer.
Orthofix's (OFIX) fourth-quarter earnings and revenues beat their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
Orthofix Medical Inc (OFIX) released its 8-K filing on March 5, 2024, showcasing a year of substantial growth and operational efficiency